Portfolio (Quarterly)
Guide ↗
Velan Capital Investment Management LP
· CIK 0001848809| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | — | PRAXIS PRECISION MEDICINES I | — | 88,781.0 | $29.7M | 18.10% | -12K | -11.9% | $334.79 | — |
| 2 | MPLT | MAPLIGHT THERAPEUTICS INC | Healthcare | 492,893.0 | $17.7M | 10.76% | — | — | $35.84 | -64.8% |
| 3 | — | SUTRO BIOPHARMA INC | — | 512,160.0 | $17.0M | 10.36% | — | — | $33.20 | — |
| 4 | IMMX | IMMIX BIOPHARMA INC | Healthcare | 1,085,000.0 | $11.2M | 6.81% | +345K | +46.6% | $10.31 | +35.2% |
| 5 | TARA | PROTARA THERAPEUTICS INC | Healthcare | 2,844,652.0 | $10.9M | 6.62% | — | — | $3.82 | -0.0% |
| 6 | ABVX | ABIVAX SA | Healthcare | 65,630.0 | $8.7M | 5.33% | -11K | -14.8% | $133.26 | -14.9% |
| 7 | — | TENAX THERAPEUTICS INC | — | 549,985.0 | $8.0M | 4.87% | -33K | -5.7% | $14.55 | — |
| 8 | — | ANTERIS TECHNOLOGIES GLOBAL | — | 700,000.0 | $6.9M | 4.20% | — | — | $9.85 | — |
| 9 | — | EDESA BIOTECH INC | — | 827,500.0 | $6.7M | 4.10% | — | — | $8.13 | — |
| 10 | EVMN | EVOMMUNE INC | Healthcare | 451,255.0 | $6.0M | 3.65% | +5K | +1.1% | $13.29 | -0.5% |
| 11 | — | AVALO THERAPEUTICS INC | — | 324,452.0 | $6.0M | 3.65% | +139K | +75.3% | $18.48 | — |
| 12 | XNCR | XENCOR INC | Healthcare | 255,000.0 | $4.1M | 2.50% | +5K | +2.0% | $16.10 | +61.9% |
| 13 | RZLT | REZOLUTE INC | Healthcare | 750,000.0 | $3.9M | 2.38% | — | — | $5.20 | -11.2% |
| 14 | HRTX | HERON THERAPEUTICS INC | Healthcare | 8,753,290.0 | $3.7M | 2.27% | — | — | $0.43 | -23.5% |
| 15 | VRCA | VERRICA PHARMACEUTICALS INC | Healthcare | 471,559.0 | $2.9M | 1.76% | — | — | $6.12 | -7.0% |
| 16 | CCCC | C4 THERAPEUTICS INC | Healthcare | 570,000.0 | $2.7M | 1.62% | NEW | — | $4.67 | -17.6% |
| 17 | — | EUPRAXIA PHARMACEUTICALS INC | — | 352,000.0 | $2.3M | 1.42% | — | — | $6.61 | — |
| 18 | ADMA | ADMA BIOLOGICS INC | Healthcare | 250,000.0 | $2.1M | 1.27% | NEW | — | $8.37 | +11.6% |
| 19 | RNTX | REIN THERAPEUTICS INC | Healthcare | 1,700,000.0 | $1.8M | 1.08% | NEW | — | $1.04 | -26.7% |
| 20 | LYEL | LYELL IMMUNOPHARMA INC | Healthcare | 105,000.0 | $1.5M | 0.90% | +3K | +2.9% | $14.05 | +3.4% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%